The global breast implants market was valued at USD 3 billion in 2023 and grew at a CAGR of 8% from 2024 to 2033. The market is expected to reach USD 6.47 billion by 2033. Given the rising disposable income and improved access to these services, the increasing demand for breast augmentation will drive the growth of the global breast implant market.

Market Introduction:

Breast implants are medical devices that help in the augmentation or reconstruction of a woman's breasts according to consumer preferences with different shapes and sizes. They consist of a silicone outer shell filled with saline or silicone gel. They are primarily used for cosmetic augmentation, breast reconstruction, and corrective surgery. Cosmetic breast augmentation enhances the appearance of breasts for aesthetic reasons. Breast implants are also used in breast reconstruction surgeries, particularly for women who have undergone mastectomy due to breast cancer. Plastic surgeons are the primary providers of breast implant surgeries. The need for breast implants varies from some getting it to improve their appearance and boost self-esteem. In contrast, for others, it's a vital component of recovering from breast cancer or addressing congenital deformities. Breast implants serve important roles in both cosmetic enhancement and medical reconstruction.

Get an overview of this study by requesting a free sample

Recent Development

• Ankit Bharat, MD, FACS, a cardiothoracic surgeon at Northwestern University Feinberg School of Medicine in Chicago, Illinois, used big breast implants to save the life of a patient whose lungs had failed from a serious infection. This is an impressive example of clinical innovation. Dr. Bharat, the Harold L. and Margaret N. Method Professor of Surgery and Chief of Thoracic Surgery at Feinberg, put a novel approach into practice. The medical staff placed large implants into the patient's chest cavity to stabilize the heart in response to the severe infection and the necessity to maintain blood flow without functioning lungs. These implants served as temporary stand-ins for the extracorporeal membrane oxygenation machine, allowing blood circulation.

Market Dynamics:

Drivers

The increasing disposable income and improved access to services – societal and Cultural beauty standards often prioritize larger or more symmetrical breasts as the ideal norm of beauty for a woman. These standards and expectations exert significant influence on women, compelling them to seek breast augmentation as a means of conforming to these ideals. Moreover, the proliferation of cosmetic procedures by celebrities and social media influencers in mainstream media has heightened awareness and acceptance of these procedures, thereby driving their demand. Advancements in medical technology and surgical techniques have played a crucial role in enhancing the safety and efficacy of breast implants. This improved safety has augmented the increasing demand for breast augmentation procedures. The increasing disposable income and improved access to services will contribute to the increasing demand for breast implants.

Restraints:

The high costs of breast implants – Breast augmentation surgery involves various expenses, including surgeon fees, anaesthesia costs, facility fees, preoperative tests, postoperative care, and the cost of the implants themselves. These expenses can add up significantly, making breast augmentation financially out of reach for some individuals. The cost of breast implants varies depending on factors such as the type of implant, the surgeon's expertise and location, the surgical facility, and any additional procedures required. Furthermore, insurance coverage for breast augmentation is often limited. Most health insurance plans do not cover elective cosmetic procedures, including breast augmentation, for aesthetic reasons. Therefore, out-of-pocket expenses can be substantial. The high cost of breast implants can limit the market’s growth.

• To draw attention to reports of squamous cell carcinoma and different lymphomas in the scar tissue or capsule that encircles breast implants, the U.S. Food and Drug Administration (FDA) released a safety communication. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), also present in the capsule, differs from the lymphomas. The FDA acknowledged receiving ten reports of squamous cell carcinoma and twelve reports of various lymphoma types associated with breast implants.

Opportunities:

The growing number of clinics and other relevant facilities offering these services – cosmetic procedures have become more mainstream and accessible to a wider range of individuals. This accessibility is facilitated by the expansion of plastic surgery clinics and the availability of qualified surgeons in various geographical areas. Furthermore, introducing new insurance policies covering financing options for certain breast augmentation cases has made the procedure more financially feasible for more consumers. Technological advancements and Ongoing research in implant materials and surgical techniques have led to innovations that offer patients more options and potentially better outcomes. These technological advancements have improved the safety and efficacy of breast implants and enhanced patient satisfaction by offering more personalized solutions. Therefore, the growing number of providers and availability of more financing options will contribute to the market's growth.

• CollPlant Biotechnologies, a company focused on regenerative and aesthetic medicine that creates novel products and technologies for tissue regeneration and organ manufacturing using non-animal-derived collagen, has announced the start of a pre-clinical trial aimed at assessing commercial-size, 3D-bioprinted, regenerative breast implants. No commercial products are available right now that enable the regeneration of soft tissues like the breast.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global breast implant market, with a 42% market revenue share in 2023.

Societal beauty norms and standards often driven by celebrities embracing larger or more symmetrical breasts lead to many women seeking breast augmentation. Increased awareness and acceptance of cosmetic procedures, fuelled by advancements in medical technology and the widespread social media presence of influencers who have undergone these surgeries. Technological advancements in breast implant technology offer patients more options and better outcomes, further driving demand. Additionally, the growing number of plastic surgery clinics and the availability of qualified surgeons have increased accessibility. Enhanced insurance coverage in the region has also made the procedure more financially feasible for some patients, further contributing to its growing popularity.

Check the geographical analysis of this market by requesting a free sample

• Women can now receive the newest generation of breast implants from Canadian plastic surgeons, which have been clinically shown to have low complication rates1. Health Canada has licenced Sientra, the first new manufacturer of silicone gel breast implants in almost 20 years. Clarion Medical Technologies sells Sientra. With the most up-to-date gel technology and scientifically validated data, their High-Strength Cohesive Silicone Gel Breast Implants offer an unparalleled safety profile1. The industry's most extensive warranty programme is the Sientra Platinum20. Only board-certified plastic surgeons in Canada are authorized to sell the exclusive Sientra brand of breast implants, ensuring greater patient safety.

Product Segment Analysis

The product segment is divided into silicone breast implants and saline breast implants. The silicone breast implants segment dominated the market, with a market share of around 77% in 2023. silicone implants offer a natural look and feel of breast tissue, providing a more aesthetically pleasing outcome. They are less prone to rippling and wrinkling. Silicone implants also offer durability and longevity, with a lower risk of deflation or rupture than saline implants, reducing the need for future surgeries. They have a lower incidence of capsular contracture, thereby minimizing complications. Silicone implants come in various shapes, sizes, and profiles, allowing for greater customization to suit individual preferences and anatomical characteristics. The natural look and feel, reduced risk of complications, versatility, and aesthetic benefits of silicone implants make them the preferred choice for many women considering breast augmentation or reconstruction, explaining their dominance in the market.

Shape Segment Analysis

The shape segment is divided into round and anatomical. The round segment dominated the market, with a market share of around 64% in 2023. Round shape offers symmetry, allowing for consistent results across various breast sizes and shapes, making them suitable for cosmetic augmentation and reconstructive surgeries. Round implants offer enhanced cleavage and projection, fulfilling the aesthetic desires of patients. Round implants do not have a specific orientation, eliminating concerns about rotation within the breast pocket. They are more affordable than anatomical implants, making them a cost-effective option for patients. With lower complication rates and ease of surgical placement, round implants are preferred by both patients and surgeons for their reliability and positive results. Their versatility, reduced rotation risk, affordability, lower complication rates, and ease of surgical placement contribute to their widespread popularity and dominance in the breast implant market.

• The For Every BODY ad, launched by AbbVie subsidiary Natrelle, demonstrates how patients with different body types can benefit from the brand's breast implant offerings. Natrelle is reminding customers that it offers customization choices for breast implants that match all shapes and curves as part of its promotional campaign. The endeavour aims to enlighten women on the range of breast implant choices accessible to them and involve them in the process of consulting with a plastic surgeon before undergoing a procedure.

Application Segment Analysis

The application segment is divided into reconstructive surgery and cosmetic surgery. The cosmetic surgery segment dominated the market, with a share of around 66% in 2023. Cosmetic surgeries like Breast augmentation are highly popular, and it is used to enhance breast size, shape, or symmetry. Cosmetic procedures like breast augmentation have surged in popularity as they offer individuals the opportunity to enhance their physical appearance, boosting confidence and self-esteem. Technology advancements have made procedures safer, more efficient, and with shorter recovery times, attracting more people to consider them. Additionally, the diminishing stigma surrounding cosmetic surgery has encouraged greater acceptance and adoption. The influence of celebrities and social media influencers has also contributed to the acceptance of cosmetic procedures by normalizing them.

End-use Segment Analysis

The end-use segment is divided into hospitals, cosmetology clinics, ambulatory surgical centers, and others. The hospital segment dominated, with a market share of around 47% in 2023. Hospitals are preferred venues for breast implant procedures due to their adherence to strict safety standards and regulations, ensuring a sterile environment and optimal conditions for surgery. Medical staff's expertise is another key factor driving patients to seek breast augmentation in hospitals. Hospitals offer comprehensive care facilities, including preoperative consultations, state-of-the-art surgical suites, and postoperative recovery areas. Additionally, hospitals provide access to specialized medical services and resources, contributing to breast implant procedures' overall safety and success. Hospitals are equipped to provide immediate and comprehensive emergency care in a medical emergency.

Some of the Key Market Players:

• ALLERGAN
• Establishment Labs S.A.
• C. Aesthetics
• GROUPE SEBBIN SAS
• Guangzhou Wanhe Plastic Materials Co., Ltd.
• HANSBIOMED CO. LTD.
• LABORATOIRES ARION
• Mentor Worldwide LLC
• Polytech Health & Aesthetics GmbH
• Shanghai Kangning Medical Supplies Ltd.

Report Description: